AUSTRALIAN-LISTED cannabinoid specialist company AusCann has announced the apointment of a new chief medical advisor, international medical cannabis expert Dr Danial Schecter (pictured below).
Schecter is the co-founder and medical director of the Canadian Cannabinoid Medical Clinic, a practicing physician and a leader in the field of cannabinoid medicine.
Canada has allowed the use of cannabinoid medicines since 2001, with Schecter spearheading the creation of the 'Patient Handbook on Medical Cannabis' used as a patient education tool.
A clear access system for cannabinoid medicines for Canadian physicians was established in 2014.
"Australian physicians have not been taught about the endocannabinoid system in medical school or post graduate training," Schecter said.
"In order to rectify this situation, to allow patients access to cannabinoid medicines, it is crucial to support medical education."
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Jun 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Jun 17
